Previous studies have documented the presence of increased red blood cell aggregability in patients with ischemic heart and brain diseases. We adapted a simple slide technique and image analysis to reveal the state of erythrocyte adhesiveness/aggregation (EAA) in the peripheral blood of 206 such patients and in 174 controls. A significant (P<0.0001) correlation was noted between the EAA state and both fibrinogen concentrations and erythrocyte sedimentation rate in the whole cohort. Noteworthy was a highly significant increment in the EAA state in a subgroup of 49 patients who had normal fibrinogen concentrations when compared to matched healthy controls. This was also the case in 82 patients who had a normal erythrocyte sedimentation rate. Thus, the EAA assay appears to have the advantage of revealing the presence of acute phase response sticky proteins not detected by either the erythrocyte sedimentation rate or clottable fibrinogen in some patients with a documented ischemic vascular disease. 
PATIENTS AND METHODS

2.1
PATIENTS AND CONTROLS Consent was obtained from all the individuals who participated in the present study according to the approval of the local ethics committee. Included were two groups of patients with ischemic vascular diseases and one of healthy controls. Group assignment was as follows:
1. Ischemic heart disease: patients with chest pain who were admitted for observation and in whom acute myocardial infarction was ruled out. Documentation of ischemic heart disease was by means of a history of myocardial infarction (MI), coronary artery bypass graft surgery (CABG), present or past positive coronary angiography, or a positive thallium scan. 2. Ischemic neurological event: patients with an acute transient ischemic attack or ischemic stroke in whom a hemorrhagic stroke was ruled out by means of computerized tomography. 3. Healthy controls: members of the medical staff and members of a health club who volunteered to participate in the study.
Excluded from the present study were individuals who had any underlying inflammatory or malignant disease as well as those who were on steroidal or non-steroidal anti-inflammatory medications (except for aspirin up to a dose of 325 mg per day). In addition, we excluded individuals who had any traumatic or infectious condition including angiography, surgery or MI during the three months preceding study recruitment.
LABORATORY METHODS
VARIABLES OF THE ACUTE PHASE RESPONSE
The blood count was performed by means of the Coulter STKS electronic cell analyzer, the erythrocyte sedimentation rate by the method of Westergren [26] and the concentration of fibrinogen by the method of Clauss [27] and a Sysmex x6000 analyzer. 
INTRODUCTION
Previous studies have shown that there is an increased red blood cell aggregability in patients with ischemic heart [1-5] and brain [6] [7] [8] [9] disease. This augmented aggregation might have detrimental rheological consequences that lead to the need for therapeutic interventions for reducing the degree of these cellular interactions. [10] [11] [12] [13] [14] [15] [16] . There are various reasons for the appearance of increased erythrocyte aggregation in patients with ischemic vascular diseases, among which are the presence of an acute phase response and an increased synthesis of adhesive proteins, [17] hyperlipidemia, [18] and changes in the erythrocyte's membrane. [19] We have recently adapted a simple slide technique and image analysis to reveal the erythrocyte adhesiveness/aggregation state in the peripheral blood. [20] [21] [22] [23] [24] [25] The present study was conducted in patients with documented ischemic heart and brain disease. We could note the expected significant correlation between the results of this test and either fibrinogen concentration or the erythrocyte sedimentation rate. However, an unexpected and significant increment in the EAA state was found in a subgroup of patients who had normal fibrinogen concentrations and a normal rate of erythrocyte sedimentation, suggesting a potential advantage of the erythrocyte adhesiveness/aggregation test (EAAT) in unmasking rheological information that is not provided by either the measurement of clottable fibrinogen or the erythrocyte sedimentation rate. September/October 2000
PREPARATION OF PERIPHERAL BLOOD SLIDES
The guidelines for the preparation of the peripheral blood slides were reported elsewhere. [28] Briefly, blood was drawn into a syringe containing sodium citrate (one volume of 3.8% sodium citrate and three volumes of whole blood). Several large drops of blood were placed on a slide that was held for 2 to 3 seconds at an angle of 45°s o that the blood could run down by gravity, leaving a fine film. The slides were then dried at room temperature while in a completely horizontal position. Automatic staining was performed by means of the HEMA TEK slide stainer (AMES) and a HEMA TEK bloc colorant stain pack (Bayer Diagnostics).
INFLAMMATION METER (INFLAMET™)
For analysis of the slides, we used an image analysis system (INFLAMET™) [20] [21] [22] [23] [24] [25] consisting of a Pentium Win 95 equipped with a Matrox Meteor colour frame grabber, a colour CCD camera and a microscope which was operated at x 200 magnification, resulting in an image resolution of 0.4 micron per pixel. Nine images were taken from each slide. The fields of view were chosen systematically to sample different regions on the slide. Each image is processed separately and the outputs are then averaged to form the final slide outputs. The nine fields of view cover a total area of 0.6 mm 2 .
ERYTHROCYTE ADHESIVENESS/AGGREGA-TION TEST (EAAT)
The erythrocyte adhesiveness/aggregation state in the peripheral blood was determined by using the same image analysis system (INFLAMET™). We have used color characteristics to classify image pixels into two classes:
Class 1: Aggregates of erythrocytes Class 2: Everything else (plasma, platelets, leukocytes)
A description of one-point and two-point statistics for this classification turns out to require very few parameters. The main reason for this is that the image statistics are homogenous (positionindependent) and isotropic (direction-independent). The one point statistics are completely described by the probability of a pixel belonging to Class 1, which we name Erythrocyte Percentage (EP). This is the proportion of image area covered by erythrocytes. The two-point statistics are described by the probability p 1 (r) of a pixel belonging to Class 1, given that it is a distance r from a pixel Class 1, and similarly the probability p 2 (r) of a pixel belonging to Class 2, given that it is a distance r from a pixel of Class 2. These probabilities are equal to 1 for r = 0 and decrease as functions of r. As r grows without bound they tend to EP and 1-EP, respectively. The typical size of erythrocyte aggregates and of plasma spaces may be quantified by the rate of decrease of the functions p 1 (r) and p 2 (r). In the following discussion we will deal with p 1 , where it is understood that the treatment of p 2 is similar. If, for example, the erythrocyte aggregates are very small, the probability p 1 (r) will decrease very fast as a function of r because at a quite a short distance from a point of Class 1, a pixel has no longer a marked preference to belong to Class 1. A typical distance scale for the size of aggregates may be defined by the negative inverse of the derivative of p 1 at r = 0. The derivative must be computed numerically, which we did using the following algorithm:
• Choose a threshold somewhat smaller than 1 • Find r 0 such as p 1 (r 0 ) = threshold • Estimate p 1 '(0) as:
• The desire distance scale is:
In practice we chose threshold = 0.7 since down to this value p 1 appears to be linear. We define the aggregation radius (AR) as r 0 -differing by a constant factor of 0.3 from above. Vacuum Radius (VR) is the analogous quantity defined for class 2.
STATISTICAL ANALYSIS
Means ± SD, Student's t-test and the Pearson coefficient of correlation were carried out by means of the SPSS package. By using the paired t-test, we compared a subgroup of patients who had either normal concentrations of fibrinogen or a normal erythrocyte sedimentation rate to healthy controls who presented with exactly the same values. Thus, a patient with a fibrinogen concentration of 292 mg/dL was compared to a healthy individual with the same value, etc.
RESULTS
In the present study, we examined a total of 134 patients with an ischemic heart disease (age 62±13 years; 89 males and 45 females), 72 with an ischemic neurological event (age 70 ± 12 years; 39 males and 33 females) and 174 healthy individuals (age 39 ± 17 years, 92 males and 82 females). The correlation between the three variables of the erythrocyte adhesiveness/aggregation test, i.e., the VR, AR and EP, and the hemoglobin concentration and the hematocrit values in 380 individuals (patients and controls) are shown in Table 1 . These correlations were also significant when they were applied to the erythrocyte sedimentation rate (Table 1) .
There was a highly significant correlation between the three variables of the EAAT and the concentration of fibrinogen as well as the erythrocyte sedimentation rate (Table 2) . However, when the results obtained in a subgroup of patients in whom the concentration of fibrinogen was found to be within normal limits (i.e., 200-400 mg/dL) were compared to the normal values in the controls, significant differences in the variables of the erythrocyte adhesiveness/aggregation were observed, despite comparable fibrinogen concentrations (paired t-test, Table 3 ). Similar differences could also be seen in a subgroup of patients who had not only comparable fibrinogen concentrations but also exactly the same erythrocyte sedimentation rate (Table 4) . In an analysis of a smaller group, we could reproduce the results and show that this is not an age-related effect (Table 5 ).
DISCUSSION
We adapted a simple slide test coupled with a precise image analysis system to study the erythrocyte adhesiveness/aggregation state in the peripheral blood of patients with documented ischemic heart and brain diseases. As expected, a significant correlation was noted between the adhesiveness/aggregation state and the concentration of fibrinogen in both the patients and controls. In effect, fibrinogen has been shown in the past to be a major determinant in the appearance of aggregated erythrocytes in the peripheral blood [29] although other acute phase response proteins could participate as well [17, 18] . However, our main intent in conducting this study was to determine whether the EAAT is capable of disclosing information that is not available by looking at the results of either clottable fibrinogen or the sedimentation rate. To do so, we matched patients and controls who had exactly the same within normal limits (200-400 mg/dl) fibrinogen concentrations. It turned out that a clear and significant increment in the EAAT values could be seen in the group of patients with ischemic vascular diseases as opposed to the controls (Table 3) . In a further sub-analysis, we could show the same results for patients and controls who had an identical erythrocyte sedimentation rate: again, a highly significant increment in the EAAT existed in the patients as opposed to the controls. Our conclusion is that the direct observation of the aggregated erythrocytes made possible by using the slide test discloses information that is not demonstrated by either clottable fibrinogen concentrations or the erythrocyte sedimentation rate in some of the patients. There are multiple causes that can increase the adhesiveness and aggregation of red blood cells in the peripheral blood of patients with ischemic vascular disorders, including proteins of the acute phase response [17, 18] hyperlipidemia [30] and changes in the composition of the erythrocyte membrane [19, 31] . The potential additional diagnostic value of our test is in that while the above-mentioned factors can accelerate the sedimentation rate, our test was clearly positive in a group of patients in whom the erythrocyte sedimentation rate was observed as being within normal limits. Thus, our slide test might be a sensitive test for detecting the presence of a smoldering inflammatory response in a group of individuals with relatively normal fibrinogen concentrations or erythrocyte sedimentation rates. Although sensitive CRP assays could be used for this purpose, the importance of directly diagnosing the presence of red blood cell hyperaggregability [32] lies in the potential therapeutic applications that might result from this information [16] .
Although the mechanisms of increased erythrocyte adhesiveness/aggregation were not investigated in the current work, the significant correlation between the EAAT and fibrinogen concentrations that was observed when the group was evaluated as a whole is suggestive that this molecule does have some role in the induction and on the maintenance of an increased cell aggregability. The fact that we could increase the aggregability of the cells by using an intravenous infusion of gamma globulin [22] as well as our yet unpublished observations that this aggregability can be attenuated by reducing cholesterol and triglyceride concentrations in hyperlipidemic individuals, raises the possibility that we are facing a kind of a "summarizing" effect of various aggregatory forces that operate on the cells in the peripheral blood of a given patient.
The use of image analysis to detect the aggregability of red blood cells is not new and has been reported in the past [33] . The novel approach is that we use no dilution or washing steps and that the slide test is extremely easy to perform. At the moment we do not know if the aggregation radius and the vacuum radius have any physiological significance except the idea that they give for the typical size of erythrocyte aggregates and plasma spaces, respectively. However, we are currently investigating the relations between the morphology of the aggregation and the inter erythrocytic adhesion forces. It remains to see whether the most round and circular aggregates represent the most sticky cells. This might have consequences in terms of flow in the microcirculation.
The present study was performed in patients with both ischemic heart and brain disease. We assume that both have similar etiologies in terms of the presence of atherosclerosis smoldering inflammation as well as similar risk factors. However, we could reproduce the results in a group of patients with ischemic brain disease solely (to be published elsewhere). Our present study favors, therefore, the notion that the findings are not confined to a single clinical entity and might be related to the underlying pathophysiological process.
Finally, one has to be aware that various optical methodologies have been used to quantitate the aggregability of red blood cells including the erythroaggregometer (Regules, France), Laser-assisted optical rotational (cell analyzer, Mechatronics, Netherlands) and the fully automatic erythrocyte aggregometer (Myrene, Ger-many) [34] . However, we introduced our slide test due to its simplicity, low cost and a potential of becoming a real time (almost bed-side) methodology. The question was therefore, is it superior to the indirect determination that one can obtain by using the westergen sedimentation rate [35] .
In conclusion, we have demonstrated that a simple slide test and image analysis enables the detection of the presence of aggregated red blood cells in the peripheral blood of patients with ischemic heart and brain diseases. Of interest was the discovery that the test remained positive even when fibrinogen concentrations or the erythrocyte sedimentation rate were comparable to those obtained in a control group of healthy volunteers. Thus, the EAAT might be useful for unmasking relevant information that relates to the acute phase response that is not always given by either determining the concentration of clottable fibrinogen or the erythrocyte sedimentation rate.
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